| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 55.68B | 51.16B | 55.51B | 52.98B | 46.79B | 37.69B |
| Gross Profit | 17.71B | 17.11B | 17.40B | 14.99B | 11.52B | 10.44B |
| EBITDA | 6.52B | 5.98B | 6.47B | 4.92B | 2.34B | 2.11B |
| Net Income | 4.94B | 4.79B | 4.32B | 3.01B | 899.00M | 273.00M |
Balance Sheet | ||||||
| Total Assets | 62.46B | 64.96B | 63.40B | 62.17B | 56.28B | 51.09B |
| Cash, Cash Equivalents and Short-Term Investments | 10.47B | 12.49B | 12.38B | 12.34B | 8.03B | 7.26B |
| Total Debt | 5.69B | 6.03B | 5.95B | 6.59B | 7.57B | 6.29B |
| Total Liabilities | 18.05B | 17.05B | 18.43B | 19.53B | 19.29B | 17.21B |
| Stockholders Equity | 42.92B | 47.74B | 43.43B | 40.20B | 34.65B | 31.44B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.56B | 4.04B | 3.84B | -351.00M | -104.00M |
| Operating Cash Flow | 0.00 | 4.76B | 4.80B | 4.30B | 174.00M | 294.00M |
| Investing Cash Flow | 0.00 | -1.03B | -1.14B | 413.00M | 59.00M | -733.00M |
| Financing Cash Flow | 0.00 | -2.57B | -2.41B | -1.60B | -83.00M | -1.42B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥45.39B | 8.51 | ― | 3.53% | -7.83% | 13.79% | |
74 Outperform | ¥132.87B | 49.21 | ― | 0.67% | 8.51% | -17.90% | |
70 Outperform | ¥195.64B | 10.74 | ― | 4.09% | -2.00% | 23.48% | |
67 Neutral | ¥102.58B | 13.18 | ― | 3.88% | -8.00% | -7.64% | |
64 Neutral | ¥27.31B | 9.28 | ― | 3.53% | 4.47% | 9.89% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥304.78B | 18.03 | ― | 5.28% | -2.31% | -1.17% |